News
HistoSonics is shopping for a potential buyer of its approach to destroying liver tumors with focused sound waves, according ...
Background: Hepatoblastoma (HBL) and hepatocellular carcinoma (HCC ... of this study was to evaluate the combined use of the ultrasound examination and the assessment of the patients' clinical ...
Hepatocellular carcinoma (HCC), the most common form of liver cancer, continues to pose a significant global health challenge ...
LIVER CANCER, the third leading cause of cancer-related deaths globally, is primarily attributed to hepatocellular carcinoma ...
Hepatocellular carcinoma (HCC) is the most prevalent form ... is crucial. The use of ultrasound, along with alpha-fetoprotein (AFP) testing, is common for surveillance. However, these methods ...
HistoSonics today announced 12-month follow-up clinical data from its prospective HOPE4LIVER trials evaluating its ...
9d
News-Medical.Net on MSNSerum hsa_circ_101555 as a promising biomarker for hepatocellular carcinomaHepatocellular carcinoma (HCC) represents the most prevalent malignancy in Egypt and globally. However, non-invasive diagnostic/prognostic biomarkers for early detection of HCC are still lacking.
EvoLiver, a blood test that detects early-stage liver cancer with high accuracy, has gained breakthrough device designation ...
11d
News-Medical.Net on MSNMursla Bio receives FDA breakthrough device designation for EvoLiver testMursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results